Relmada Therapeutics
RLMD
RLMD
85 hedge funds and large institutions have $316M invested in Relmada Therapeutics in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 32 increasing their positions, 20 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2.26% more ownership
Funds ownership: 56.93% → 59.19% (+2.3%)
6% less capital invested
Capital invested by funds: $335M → $316M (-$18.9M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
85
Holding in Top 10
1
Calls
$13.4M
Puts
$5.65M
Top Buyers
| 1 | +$17.1M | |
| 2 | +$11.3M | |
| 3 | +$2.51M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$2.45M |
| 5 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
+$1.5M |
Top Sellers
| 1 | -$18.9M | |
| 2 | -$5.69M | |
| 3 | -$3.2M | |
| 4 |
California Public Employees Retirement System
Sacramento,
California
|
-$1.03M |
| 5 |
BlackRock
New York
|
-$578K |